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The focus of the study is an intercomparison of laboratories’
dose-assessment performances using the cytokinesis-block
micronucleus (CBMN) assay as a diagnostic triage tool for
individual radiation dose assessment. Homogenously X-irradi-
ated (240 kVp, 1 Gy/min) blood samples for establishing
calibration data (0.25–5 Gy) as well as blind samples (0.1–6.4
Gy) were sent to the participants. The CBMN assay was
performed according to protocols individually established and
varying among participating laboratories. The time taken to
report dose estimates was documented for each laboratory.
Additional information concerning laboratory organization/
characteristics as well as assay performance was collected. The
mean absolute difference (MAD) was calculated and radiation
doses were merged into four triage categories reflecting clinical
aspects to calculate accuracy, sensitivity and specificity. The
earliest report time was 4 days after sample arrival. The
CBMN dose estimates were reported with high accuracy (MAD
values of 0.20–0.50 Gy at doses below 6.4 Gy for both manual
and automated scoring procedures), but showed a limitation of
the assay at the dose point of 6.4 Gy, which resulted in a clear
dose underestimation in all cases. The MAD values (without 6.4
Gy) differed significantly (P¼ 0.03) between manual (0.25 Gy,
SEM¼ 0.06, n¼ 4) or automated scoring procedures (0.37 Gy,
SEM¼ 0.08, n¼ 5), but lowest MAD were equal (0.2 Gy) for
both scoring procedures. Likewise, both scoring procedures led
to the same allocation of dose estimates to triage categories of
clinical significance (about 83% accuracy and up to 100%
specificity).  2013 by Radiation Research Society
INTRODUCTION
In cases of unclear radiation exposures, biological
dosimetry can be a useful tool to confirm whether an
individual was actually exposed to ionizing radiation and, if
necessary, to provide information concerning the dose range
and homogeneity of exposure. A great deal of experience has
been gained with biological dosimetry in different radiolog-
ical emergencies during the last decades. In the last 10 years
there has been much effort to prepare for a large-scale
accident. One major problem after a large-scale event is the
large number of samples that would have to be analyzed in a
fast and reliable manner. Therefore, several strategies
(networking, new scoring strategies, automation and method
improvement) have been developed to achieve a higher
sample throughput. For biodosimetry purposes, several well
established cytogenetic assays exist to cover the different
exposure scenarios and new molecular methods are emerging
(1–3). These assays will all be performed in parallel, as a
single biodosimetry technique cannot fully address the
biodosimetry requirements in complex exposure scenarios
(4). In the case of a large-scale radiation accident, a single
cytogenetic laboratory would be quickly overwhelmed by the
large number of samples. Therefore, several biodosimetry
networks have been established on a national (5, 6),
international (7–9) and global level (10–12) to be better
prepared to manage a high sample throughput. One important
lesson gained from international intercomparison studies with
the most validated biodosimetry method, the dicentric
chromosome assay, is the need to harmonize and standardize
the method among different laboratories to get comparable
data. In addition, it remains necessary for each laboratory to
generate its own calibration curves to be able to provide
reliable dose estimations by biological dosimetry (8).
The lymphocyte cytokinesis-block micronucleus
(CBMN) assay was developed in 1985 (13) and is now a
standard method that is well established in the field of in
vitro genetic toxicology testing (14), population monitoring
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and radiation biodosimetry (15). Micronuclei (MN) may
arise from acentric fragments or whole chromosomes. They
are small spherical objects with the same staining property
and morphology as the two nuclei within the plasma of the
binucleated cell (15). An international collaborative network
on micronucleus frequency in human populations called
‘‘HUMN’’ (HUman MicroNucleus) was launched in 1997
and counts more than 40 participating laboratories from all
over the world (16). Within this project detailed scoring
criteria of the CBMN assay were defined and standardized
(17). The various standard protocols for culturing and
scoring in the different laboratories were summarized and
compared and the impact of age, gender, diet and lifestyle
factors on this biomarker has been well documented (18).
The CBMN assay has also been recommended by the
International Atomic Energy Agency as a biodosimeter for
the exposure to ionizing radiation (15). Many studies have
shown that the frequency of micronuclei in binucleated cells
shows clear reproducible dose-effect curves for different
radiation qualities (19–21). Today, the CBMN assay is a
well established and thoroughly validated method in
biological dosimetry. The CBMN and dicentric assays are
both robust biomarkers which allow investigations weeks or
months after an assumed in vivo radiation exposure (22, 23),
but the CBMN assay is much easier to perform and faster.
Both methods are suited for automation and are under
investigation within EU project ‘‘Multibiodose’’ (24) whose
goal it is to make available rapid emergency biodosimetry in
case of a large-scale radiation accident. The results achieved
so far in terms of automation of these techniques are very
promising (25, 26).
This NATO exercise was organized under the umbrella of
the NATO Research Task Group HFM-099 RTG-033
‘‘Radiation Bioeffects and Countermeasures’’ to compare
the performance and properties of established cytogenetic
dosimetry tools, such as the CBMN assay and dicentric
analysis with novel emerging molecular dosimetry methods
(e.g. c-H2AX assay and gene expression). This article
presents the findings and discusses the outcome of the
laboratory intercomparsions of performance for dose assess-
ment using the CBMN assay as a diagnostic tool for rapid
emergency biodosimetry. It focuses on manual scoring results
in comparison to automated scoring results with regard to the
time needed to provide dose estimations, the reliability of
dose estimates and their discriminatory power regarding
binary dose categories representing clinically relevant
treatment groups of e.g., potentially overexposed individuals.
MATERIALS AND METHODS
Procedures Common to All Assays
Blood sampling (2–3 ml whole blood from one healthy male
individual filled in heparinized tubes), radiation exposure (X-ray
source, 240 kVp, 1 Gy/min), incubation at 378C for 2 h (repair time),
distribution of calibration (optional, 0.25–5 Gy) and blind samples
(0.1–6.4 Gy) to participating laboratories as well as collection of data
(harmonized data sheets), requested information from our participants
(questionnaire) and statistical analysis (e.g., MAD calculations, impact
of questionnaire information on MAD and binary categories of clinical
significance) represent procedures employed for all assays. To
compare absolute deviations (AD) between pairs of different
subgroups the Wilcoxon signed rank test was used, which takes
singles doses into account pairwise. To assess the quality of binary
dose assignments, the factors for sensitivity, specificity and accuracy
were used, but standard deviations were not calculated because of the
low numbers. Comparison between groups of participants was done
descriptively with these factors. A detailed description of the inter-
assay comparison is the lead article in a series of companion articles
(NATO Biodosimetry Study, Radiat. Res. 2013; 180:111–19).
Cell Culture and Scoring Procedure
Culture setup and scoring was performed in the laboratories
according to their own standard protocols. Each laboratory established
whole blood cultures for the CBMN assay, with the majority using
RPMI 1640 medium (one laboratory used MEM) and 10% FCS (in
one case 20%; Table 1). The culture time varied between 70–72 h.
Cytochalasin B was added 23–44 h after culture initiation. For the
manual scoring the slides were stained with acridine orange or giemsa,
the automated scoring was done with DAPI stained slides. The
automated scoring was performed with the software module MNScore
(MetaSystems, Altlussheim, Germany). Automated scoring means that
the yield and distribution of micronuclei (MN) in binucleated cells
(BN) has been measured with a fully automated scoring system
without intervention by a human scorer. Cells with more than 4 MN/
cell were excluded to avoid a staining bias. Semiautomated scoring
means that a trained human scorer evaluated all machine detected MN
in a second step. Furthermore, one laboratory evaluated the remaining
cells without detected MN, which was accepted here as equivalent to
conventional manual scoring as all detected binucleated cells were
completely reanalyzed by a human scorer.
Each laboratory used its own calibration curve for dose estimation.
In general the dose effect curves were following the linear-quadratic
curve model: Y ¼ C þ a* D þ b* D2. The observed frequency of
micronulei in binucleated cells ¼ Y depends on the spontaneous
frequency C and the dose D, which has a linear (a) and quadratic (b)
component (Table 2). The calibration curves and the dose were done
with estimations standard software programmes (e.g., CABAS or
DoseEstimate).
RESULTS
Six institutions participated and provided dose estimates
for each of the 10 blind samples (laboratories 1–6). Several
participants have sent more than one contribution (‘‘labo-
ratory contribution’’: one set of 10 dose estimates
corresponding to the 10 blind samples), e.g., automated,
semiautomated or manual scores, calculated based on their
own specific standard calibration curves. In total, 11
contributions by all participants provided 110 dose
estimates for data analysis.
General information of the participating institutions such
as answers to the questionnaire about their experience with
the assay, methodological details provided by all partici-
pants and the documented time required to report dose
estimates are given in Table 1.
The earliest reports on dose estimates were provided 4
days after sample arrival at the respective laboratory when
using automated scoring procedures and 7.1 days thereafter
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when using a manual scoring procedure. In total, the report
time ranged between 4–17 days after sample receipt. One
laboratory was not able to give first priority to this exercise
and therefore needed more time than the others.
Temperature logs indicated an almost constant tempera-
ture of 208C (628C) for the transport of the calibration
samples sent in July and the blind samples sent in
September. Film badges did not detect any undesired
additional radiation exposure to the samples during the
transport.
All participating institutions used their own CBMN
calibration curves (see Table 2 and Fig. 1) for dose
estimations of the blind samples. Five laboratories used the
provided blood samples in the first step of the exercise for
calibration purposes. Laboratories 1 and 4 generated new
calibration curves based on automated micronucleus scoring
and laboratory 5 established a curve by manual scoring.
Laboratory 2 used the samples to increase the number of
donors (and cells) of their calibration curve. And laboratory
3 used the samples for cross checking the reference samples
against their own calibration curve to ensure that the
existing curve could be used instead of generating a new
curve. In total 10 different dose effect curves were used
during the exercise.
The number of analyzed cells per dose point varied
significantly (140 to 4,000 cells, Table 3), when complete
slides were scanned by the automated procedures. There
were 4 ‘‘laboratory contributions’’ based on manual scoring
provided by laboratories 1, 3 and 5. Laboratory 5 analyzed
200 and 2,000 cells per sample manually. Furthermore there
were 5 contributions by 4 laboratories based on automated
scoring, which were supplemented by 2 contributions,
where semiautomated analysis was performed. Concerning
the radiation quality, 5 contributions were based on
calibration curves for X rays and 6 on those for c rays. In
total, the 6 participating institutions delivered 11 different
contributions of dose estimations (Table 4).
In Fig. 2, the reported dose estimates of the 10 blind
samples are shown relative to the true absorbed doses,
sorted with increasing order. The different scoring proce-
dures can be compared directly and appear to give quite
comparable results. Only the analysis of the 6.4 Gy sample
demonstrated the limit of the assay at doses above 4.5 Gy
and shows here a clear dose underestimation in all cases. A
dose of 6.4 Gy is not included in the dose effects curves
(dose range up to 4.0 Gy with X rays) shown here. A test to
determine if this 6.4 Gy dose point could be included in the
assay was negative (P , 0.001, Wilcoxon rank test).
For the interlaboratory comparison laboratory contribu-
tions were stratified based on the scoring procedure and the
calibration curve applied for dose reconstruction (Table 4).
MAD values per irradiated samples also indicate an upper
limit in dose estimates at 6.4 Gy, since true doses were
underestimated by all laboratories with a total MAD of 2.08
Gy, which corresponds to an unacceptably high mean
difference of about 33% from the true dose. At doses below
2.5 Gy, the MAD values are small (0.14 to 0.38 Gy), which
fit the 0.5 Gy uncertainty interval introduced for triage
dosimetry of chromosomal aberrations (27). At doses of 2.6,
3.0 and 4.2 Gy, the MAD increases in the range of 0.6, 0.4
and 0.52 Gy, which is still below or near 20% of the actual
dose, and therefore still in good agreement. The number of
dose estimates which exceeds 20% of the true dose
increases at 2.6 Gy (6 dose estimates) and peaks at 6.4
Gy [10 estimates: .20% difference from actual dose, all
estimates greater than the 0.5 Gy uncertainty interval
accepted for triage biodosimetry (28)].
Because of the strong misleading impact of the highest
dose point on all MAD values, for further analysis, the
highest 6.4 Gy dose point was excluded. Analysis of
contributions based on conventional manual scoring
resulted in the lowest MAD values (0.20 and 0.20 Gy,
Table 4) when a calibration curve based on the same
radiation quality like the blind samples were exposed to was
applied. The MAD increased significantly using a calibra-
TABLE 1
Experience of Participating Institutions, Technical Characteristics and Variables in the Standard Protocols (Answers to the
Questionnaire) Related to the CBMN Assay
Institution
Laboratories
specialized in
biodosimetry
Previous
excercises
Method
established
since. . .
(month) Medium FCS (%)
Culture
time
Time,
CB
was
added to
culture
Fixtion
methanol:
acetic
acid Staining
Laboratory 1 Yes 1 72 RPMI 1640 10% 72 h 24 h 4:1 DAPI
Laboratory 2 Yes 1 12 RPMI 1640 20% 70 h 23 h 4:1 DAPI
Laboratory 3 Yes 4 48 RPMI 1640 10% 72 h 44 h 5:1 Acridine
Orange
Laboratory 4 Yes 0 360 MEM 10% 72 hr 24 h 3:1 DAPI
Laboratory 5 Yes 0 72 RPMI 1640 10% 72 h 44 h a) 5:1 Giemsa
b) 3:5
Laboratory 6 Yes 4 240 RPMI 1640 10% 70 h 24 h 4:1 DAPI
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tion curve derived after c-ray exposure (0.26–0.33 Gy,
Wilcoxon signed rank test, P ¼ 0.021). Semiautomated
scoring (0.37 and 0.46 Gy) showed significantly higher
MAD values than manual scoring (Wilcoxon signed rank, P
¼ 0.02). The automated scoring procedure received a good
performance for X rays (0.21–0.36 Gy) and increased when
estimates were based on c-ray curves (0.46–0.50 Gy,
Wilcoxon signed rank, P ¼ 0.020). Furthermore, accuracy
of manual scoring appeared significantly higher compared
to the automated scoring procedure (P ¼ 0.03), but only
when considering all laboratory contributions. However,
comparable accuracy was found for both scoring procedures
when considering only laboratory contributions with lowest
MAD values of 0.2 (Table 4).
Furthermore, is an increased number of measurements
outside the 0.5 Gy uncertainty interval was observed
relative to the true dose when using semiautomated instead
of manual scoring (3 vs. 1–2 false dose estimates) or
employing a calibration curve generated with gamma
instead of X rays (0–2 vs. 4–5 false).
One laboratory analyzed 200 and 2,000 cells per dose
point by conventional manual scoring. Remarkably, the
MAD values (0.20 and 0.21 Gy) are nearly the same and
show no improved accuracy with higher cell number. In
total, all contributions show MAD values of the dose
estimations 0.5 Gy, which corresponds well with the
uncertainty interval (Table 4).
To elucidate the reason for variability of MAD values we
examined the impact of answers from our questionnaires as
well as the impact of the scoring procedure and the
calibration source used. No association of MAD was found
with any of the factors of the questionnaire (Spearman’s
rank correlation test, P . 0.10). Also no significant
correlation was found with the scoring procedure when
using the Kruskal Wallis rank test between all three
procedures, P ¼ 0.15 or the Wilcoxon rank test between
‘‘auto’’ and ‘‘manual’’, P ¼ 0.063) and the type of
calibration curve used (Wilcoxon rank test, P ¼ 0.25).
However, these values approached significance using the
Wilcoxon signed rank test (pairwise dose dependencies),
which implies that differences are small. This is why we
compared the lowest MAD among different laboratories
using different scoring procedures as well. MAD of 0.2 Gy
were found for manual and automated scoring procedures,
which might imply comparable performance inherent to
both scoring procedures. Of course, this result has to be
validated in future studies comparing many more laborato-
ries. To reflect clinically/diagnostically/epidemiologically
relevant aspects we also aggregated CBMN based dose
estimates within binary categories. Irrespective of the
scoring procedure specificity increased for binary categories
when discriminating higher exposure groups (Table 5) and
revealed comparable values for both the manual and the
automated scoring procedure. For the first three binary
categories we found comparable values in accuracy (85–
95%) and sensitivity (97–100%) for manual and automated
scoring. These values slightly decreased for the binary
group comprising 2–4 Gy vs. .4 Gy radiation exposure,
but remained comparable for both scoring procedures in
accuracy (83.3%) and specificity (100%).
DISCUSSION
The CBMN assay is a well established cytogenetic
dosimetry method. In an emergency situation radiation
dose estimates should be provided as soon as possible to
TABLE 2
Coefficients and Characteristics of Dose Effect Curves Applied in this Study
Institution C (6SE) a (6SE) b (6SE) Radiation quality, scoring mode, scored BN cells
Laboratory 1 0.0318 (60.0043) 0.0370 (60.0114) 0.0360 (60.0044) 240 kVp X ray, automated, 38,675 BN cells
Laboratory 1 0.0274 (60.0020) 0.0614 (60.0111) 0.0163 (60.0042) 60Co c ray, automated, 94,858 BN cells
Laboratory 1 0.0133 (60.0012) 0.0456 (60.0090) 0.0322 (60.0037) 60Co c ray, semiautomated, 94,820 BN cells
Laboratory 1 0.0275 (60.0027) 0.0767 (60.0180) 0.0418 (60.0073) 60Co c ray, manual, 94,346 BN cells
Laboratory 2 0.0095 (60.0076) 0.0547 (60.0096) 0.0166 (60.0002) 240 kVp X ray, semiautomated, 184,937 BN cells
Laboratory 2 0.0394 (60.0239) 0.0535 (60.0066) 0.0154 (60.0012) 240 kVp X ray, automated, 188,436 BN cells
Laboratory 3 0.0277 (60.0170) 0.0718 (60.0407) 0.0473 (60.0963) 137Cs c ray, manual, 80,000 BN cells
Laboratory 4 0.0255 (60.0084) 0.0589 (60.0116) 240 kVp X ray, automated, 22,381 BN cells
Laboratory 5 0.0039 (60.0031) 0.0923 (60.0159) 0.0601 (60.0058) 240 kVp X ray, manual, 32,000 BN cells
Laboratory 6 0.0202 (60.0003) 0.01842 (60.0013) 0.0267 (60.0007) 60Co c ray, automated, 90,000 BN cells
TABLE 1
Extended.
Scoring
procedure
(contributions)
NATO
samples
processed
with
Time required
to report
dose
estimates
(days)
Manual
Semiautomated
Automatic (4)
priority 4
Semiautomated
Automated (2)
priority 4
Manual (1) priority 7
Automated (1) priority 4
Manual (2) priority 8
Automated (1) when appropriate 17
NATO BIODOSIMETRY STUDY 123
support clinical decision making. According to the data of
this exercise dose estimates based on automated scoring
could be provided 4 days after sample arrival at the
laboratory, but for the manual scoring procedure, 7 days
was required. A very important time factor here is the 3-day
culture time necessary to perform the assay.
One strategy to accelerate the method is to reduce the cell
numbers to be analyzed. Currently there is a recommenda-
tion to manually analyze 200 cells with the CBMN assay in
a triage mode (15, 29) comparable to the triage mode of the
dicentric assay (30). A corresponding ISO standard for the
CBMN assay is in preparation, which will probably
recommend the scoring of 200 cells per sample in a large-
scale accident. In this exercise, one laboratory separately
analyzed 200 and 2,000 cells per dose point and the MAD
values (0.20 and 0.21 Gy) did not show any improvement of
accuracy with the higher cell number.
Another improvement of the method can be achieved by
automation of scoring, which can increase the throughput
of the samples as was demonstrated by the number of cells
analyzed in this study (Table 3). Several automated
systems are available on the market and have been tested
by human monitoring (28, 31–34). In our study the scoring
system of MetaSystems (Altlussheim, Germany) was
utilized. MetaSystems can analyze a whole slide with
.2,000 cells completely automatically in less than 8 min
(35). This is 2 times faster than the manual scoring of 200
binucleated cells which takes approximately 15 min (15).
The resulting calibration curves show a good regression,
but in general curves of manual scoring were steeper by a
factor of about 2 in relationship to the curves generated by
automated scoring procedures, which can probably be
explained by the better detection efficiency of human
scorers (25, 28, 31).
Comparing the accuracy of different scoring procedures
(manual, semiautomated and automated) performed by the
same laboratory (Table 4 and laboratory 1), we find
comparable MAD values for the different scoring proce-
dures. If we focus on laboratories with similar quality
calibration curves, the blind samples show MAD values
,0.4 Gy irrespectively of the scoring procedure and the
lowest MAD (0.2) were found for manual as well as
automated scoring procedures supporting the applicability
of the faster automated scoring for biodosimetry (Table 4).
In addition, the numbers of dose estimates lying outside the
0.5 Gy uncertainty interval accepted for triage dosimetry
based on dicentric analysis (27) (or within 20% of the true
dose) were similar for the manual and the automated scoring
procedures. These comparisons are currently limited by the
sample size and number of laboratory contributions
available within this study and may be biased by other
factors such as interlaboratory performance differences and
exposure differences between radiation quality of calibra-
tion curves and blind samples. Therefore, these interpreta-
tions have to be taken with caution.
FIG. 1. CBMN dose effect curves of the participating institutions established for X and c rays (60Co or 137Cs) after conventional, automated or
semiautomated scoring.
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One limitation of our MAD approach is that for arbitrary
exposure conditions and groups of exposed victims is MAD
may not be applicable and maybe valid only under the fixed
specified experimental design of this investigation. They do
however reflect the overall accuracy of dose estimates per
laboratory contribution.
It is well known, that the CBMN assay is less sensitive for
very low doses because of the relatively high background
frequencies of MN, ranging from 2–36 MN per 1,000 BN
cells (36) resulting from individual variations depending on
age and gender (18). Due to this individual variation, the
sensitivity of the CBMN assay is in general restricted to
doses of not less than 0.2–0.3 Gy (1, 14, 15). In this
exercise, it was possible to distinguish the unexposed
sample (3 correct estimates) and the very low dose of 0.1
Gy (9 correct estimates) with an accuracy of 85–92% from
doses .0.1 Gy (Table 5). Furthermore, the results also
confirm an upper limit in applicability of the CBMN
method above .4 Gy; which has been reported by other
studies (1, 15, 35).
From the biological dosimetry point of view it is desirable
to perform dose estimates as accurately as possible. From
the clinical point of view dose ranges often provide
sufficient accuracy in order to meet urgent clinical or
diagnostic needs. Therefore, the 10 blind samples were
divided into binary categories as already described. Again,
TABLE 3
Number of Scored Cells and Observed Micronucleus Frequency [Micronuclei (MN)/1,000 Binucleated cells (BN)]
Institution
Dose (Gy)
0 0.1 0.7 1.4 2.0
BN MN/1000 BN BN MN/1000 BN BN MN/1000 BN BN MN/1000 BN BN MN/1000 BN
Laboratory 1: automated,
X ray/60Co c ray
3858 53 3955 39 2522 86 3960 213 2314 271
Laboratory 1: semiautomated,
60Co c rays
3858 26 3955 24 2521 69 3960 214 2311 299
Laboratory 1: manual,
60Co c ray
3858 45 3954 39 2520 111 3960 292 2311 435
Laboratory 2: automated, X ray 2391 28 3221 48 2767 62 2698 176 2243 277
Laboratory 2: semiautomated,
X ray
2391 11 3221 20 2767 61 2698 179 2243 267
Laboratory 3: manual, 137Cs
c ray
200 5 200 65 200 145 200 240 200 555
Laboratory 4: automated, X ray 1154 9 1435 20 1370 160 3842 160 1097 201
Laboratory 5: manual
(200 cells), X ray
200 5 200 0 200 80 200 335 200 490
Laboratory 5: manual
(2,000 cells), X ray
2000 5 2000 9 2000 77 2000 223 2000 414
Laboratory 6: automated,
60Co c rays
3986 27 3974 27 3427 69 2953 171 1576 279
Institution
Dose (Gy)
2.2 2.6 3.0 4.2 6.4
BN MN/1000 BN BN MN/1000 BN BN MN/1000 BN BN MN/1000 BN BN MN/1000 BN
Laboratory 1: automated,
X ray/60Co c ray
2098 294 1960 413 2035 509 1146 700 250 628
Laboratory 1: semiautomated,
60Co c ray
2097 324 1960 492 2033 612 1146 945 250 1008
Laboratory 1: manual,
60Co c ray
2096 478 1960 627 2031 779 1146 1212 249 1301
Laboratory 2: automated, X ray 2055 273 2127 402 2830 388 1294 576 661 708
Laboratory 2: semiautomated,
X ray
2057 264 2127 441 2830 380 1294 695 660 724
Laboratory 3: manual,
137Cs c ray
200 390 200 420 200 775 200 790 200 940
Laboratory 4: automated, X ray 841 157 576 222 524 176 365 279 140 71
Laboratory 5: manual
(200 cells), X ray
200 360 200 520 200 690 200 1250 200 1905
Laboratory 5: manual
(2,000 cells), X ray
2000 442 2000 496 2000 714 2000 1125 2000 1740
Laboratory 6: automated,
60Co c ray
2022 295 1256 367 1534 422 633 671 290 372
Note. Automated scoring: cut of cells with .4 MN/cell.
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TABLE 4
Reported Dose Estimates from Contributing Laboratories are Shown for Each Sample Irradiated with a Certain (True) Dose and
Stratified by Scoring Procedure
True doses (Gy)
With*
6.4 Gy
Without*
6.4 Gy0 0.1 0.7 1.4 2 2.2 2.6 3 4.2 6.4
Scoring procedure/Institution estimated doses (Gy)
MAD
(Gy)
MAD
(SEM)
MAD
(Gy)
MAD
(SEM)
Manual scoring
Laboratory 1: manual, 60Co c ray 0.2 0.1 0.8 1.8 2.3 2.5 3.0 3.4 4.5 4.7 0.4 0.2 0.3 0.0
Laboratory 3: manual, 137Cs c ray 0.0 0.4 1.0 1.5 2.7 2.1 2.2 3.3 3.3 3.7 0.6 0.3 0.3 0.1
Laboratory 5: manual (2,000 cells), X ray 0.0 0.1 0.6 1.2 1.9 2.0 2.2 2.8 3.6 4.7 0.4 0.2 0.2 0.1
Laboratory 5: manual (200 cells), X ray 0.0 0.0 0.6 1.7 2.2 1.9 2.3 2.7 3.9 4.9 0.3 0.1 0.2 0.0
MAD (Gy) 0.1 0.1 0.2 0.2 0.3 0.2 0.4 0.3 0.5 1.9
MAD (SEM) 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.3
Semiautomated scoring
Laboratory 1: semiautomated, 60Co c ray 0.3 0.2 0.8 1.9 2.4 2.5 3.2 3.7 4.7 4.9 0.5 0.1 0.4 0.1
Laboratory 2: semiautomated, X ray 0.0 0.2 0.8 2.0 2.6 2.6 3.7 3.4 5.1 5.6 0.5 0.1 0.5 0.1
MAD (Gy) 0.1 0.1 0.1 0.5 0.5 0.3 0.9 0.5 0.7 1.2
MAD (SEM) 0.1 0.0 0.0 0.0 0.1 0.1 0.3 0.2 0.2 0.3
Automated scoring
Laboratory 1: automated, X ray 0.4 0.2 0.8 1.8 2.1 2.2 2.8 3.2 3.8 3.6 0.5 0.3 0.2 0.0
Laboratory 1: automated, 60Co c ray 0.4 0.2 0.8 2.0 2.4 2.6 3.3 3.9 4.8 4.5 0.6 0.2 0.5 0.1
Laboratory 2: automated, X ray 0.0 0.2 0.4 1.7 2.6 2.5 3.4 3.3 4.4 5.1 0.4 0.1 0.3 0.1
Laboratory 4: automated, X ray 0.0 0.0 0.2 1.1 2.1 2.7 1.7 3.2 3.6 2.6 0.7 0.4 0.4 0.1
Laboratory 6: automated, 60Co c ray 0.3 0.3 1.1 2.1 2.8 2.9 3.3 3.6 4.6 3.3 0.8 0.3 0.5 0.1
MAD (Gy) 0.2 0.1 0.3 0.4 0.4 0.4 0.7 0.4 0.4 2.6
MAD (SEM) 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.4
MAD all performer (Gy) 0.1 0.1 0.2 0.4 0.4 0.3 0.6 0.4 0.5 2.1
SEM 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.3
Notes. Dose estimations were based on calibration curves for X rays or c rays after various scoring procedures. MAD ¼ mean absolute
difference (Gy) values were calculated for the reported dose estimates, (1) *per laboratory contribution (italicized numbers, including and
excluding the 6.4 Gy sample) and (2) bolded numbers are per sample.
FIG. 2. Reported dose estimates are shown relative to the true absorbed doses per sample (black bar) for manual (open form), semiautomated
(asterix) and fully automated scoring (solid form). The 10 samples irradiated with known doses (applied dose) are shown on the x-axis with
increasing order.
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the data suggest comparable accuracy, sensitivity and
specificity for both the manual and the automated scoring
procedures.
As stated above, our analysis is limited by the number of
contributing laboratories. We restricted our investigations to
blood samples taken from a single individual to focus on
methodological variance and exclude interindividual vari-
ance. For the same reason we varied only the dose and did
not simulate partial body radiation exposures. In general the
purpose of this exercise was to demonstrate the compara-
bility of established and new available methods under
standardized conditions. It is important to note that a real
emergency situation, when the blood samples will arrive in
the laboratories, the time delay between exposure and
sampling will have an important influence on the results, as
there are different dynamics in the persistence of the
biomarker signals used here.
CONCLUSION
Taken together, CBMN dose estimates based on auto-
mated and manual scoring were reported after 4 and 7.1
days, respectively, with a slightly better accuracy for the
manual scoring procedure when considering all laboratory
contributions and comparable accuracy when only consid-
ering laboratory contributions with the lowest MAD values.
Binary dose categories of clinical significance could be
discriminated with equal efficiency for both scoring
procedures and supports the applicability of the automated
CBMN assay for triage mode biodosimetry purposes below
6.4 Gy.
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